Table 3

Follow-up Data (Ranging from 3 to 60 Months) for 50 Patients With Acute Ischemia: Group 1 versus Group 2

CategoryGroup 1, no. (and %) (n = 19)Group 2, no. (and %) (n = 31)p value
Taking warfarin at the time of discharge17 (90)29 (94)NS
Recurrent emboli3 (16)0< 0.05
Complications of warfarin2 (10)0NS
Current anticoagulation15 (79)12 (39)< 0.05
Amputation (all occurred acutely)04 (13)< 0.05
Died3 (16)11 (36)< 0.05
  • NS = not significant.